Download PDF

Aphasia, Memory Loss, and Other Cognitive Disorders¶

Chapter 32 | Part 2: Cardinal Manifestations and Presentation of Diseases · Part 2 – Cardinal Manifestations & Presentation · Chapter 32

Key Clinical Points¶

Aphasia is defined as a deficit in the formal aspects of language (word finding, repetition, word choice, comprehension, spelling, or grammar) caused by dysfunction of the language network.
Wernicke's aphasia typically indicates a cerebrovascular cause (stroke) rather than neurodegenerative disease.
Broca's aphasia recovery peaks within 2–6 months after stroke; speech therapy is more successful in Broca's aphasia than in Wernicke's aphasia.
Pure word deafness and pure alexia without agraphia are visual/auditory disconnection syndromes, not primary sensory deficits.
Hemispatial neglect is more severe and longer-lasting after right hemisphere lesions than left hemisphere lesions.
Posterior Cortical Atrophy (PCA) is an atypical variant of Alzheimer's disease with parieto-occipital neurofibrillary degeneration.
Anti-Aβ monoclonal antibody therapy carries risks of ARIA (Amyloid-Related Imaging Abnormalities), including edema (ARIA-E) and hemorrhage (ARIA-H), which are higher in APOε4 carriers.
Gerstmann's syndrome (acalculia, dysgraphia, finger anomia, right-left confusion) localizes to the inferior parietal lobule (angular gyrus).
Bálint's syndrome involves simultanagnosia, optic ataxia, and oculomotor apraxia due to bilateral parietal lesions.
Dysarthria, apraxia of speech, and mutism do not by themselves constitute aphasia.
Aphasia occurs in ~90% of right-handers and 60% of left-handers following left hemisphere lesions.
Progressive Aphasia (PPA) is diagnosed only if the language disorder is the primary concern for at least 1–2 years.

DEFINITION & OVERVIEW¶

• Cerebral Cortex Overview: ◦ The human brain contains ~20 billion neurons over an area of 2.5 m². ◦ Primary sensory and motor areas constitute 10% of the cerebral cortex. ◦ The remaining area is the association cortex, which mediates integration of cognition, emotion, and comportment. • Large-Scale Neural Networks: ◦ (1) Left-dominant perisylvian network: Language. ◦ (2) Right-dominant parietofrontal network: Spatial orientation. ◦ (3) Occipitotemporal network: Face and object recognition. ◦ (4) Limbic network: Episodic memory and emotional modulation. ◦ (5) Prefrontal network: Comportment and executive control of cognition. ◦ Default Mode Network: Activated when not engaged in specific tasks; clinical consequences are not yet fully defined. • Aphasia Definition: ◦ Definition: Aphasia is diagnosed only when there are deficits in the formal aspects of language (word finding, repetition, word choice, comprehension, spelling, or grammar). ◦ Exclusions: Dysarthria, apraxia of speech, and mutism do not by themselves constitute aphasia. ◦ Laterality: Aphasia occurs in ~90% of right-handers and 60% of left-handers following left hemisphere lesions.

EPIDEMIOLOGY¶

• Clinical Context: Aphasia is a cardinal manifestation of cerebrovascular accidents (CVAs) and neurodegenerative diseases. ◦ Genetic Risk Factor: ◦ ARIA (Amyloid-Related Imaging Abnormalities) risk is higher in patients carrying one or two copies of APOε4.

ETIOLOGY & PATHOPHYSIOLOGY¶

• Stroke vs. Neurodegenerative Distinction: ◦ Stroke: Sudden onset, maximal deficits at start; involves cortex and underlying white matter pathways. ◦ Neurodegenerative: Greater cellular/lamellar/regional selectivity; e.g., full Wernicke's aphasia is rarely seen in neurodegenerative diseases.

Stroke Etiology¶

• Wernicke's Aphasia: ◦ Location: Posterior portion of the language network (inferior division of MCA, posterior temporal or angular branches). ◦ Associated Findings: Coexisting right hemianopia or superior quadrantanopia; mild right nasolabial flattening. ◦ Other Causes: Intracerebral hemorrhage, head trauma, neoplasm. • Broca's Aphasia: ◦ Location: Broca's area (inferior frontal convolution) and surrounding anterior perisylvian/insular cortex (superior division of MCA). ◦ Recovery: Peaks within 2–6 months after stroke; further progress is limited thereafter. ◦ Other Causes: Mass lesions (tumor, hemorrhage, abscess). • Conduction Aphasia: ◦ Location: Temporoparietal or dorsal perisylvian region; involves arcuate fasciculus. ◦ Note: Stroke-related Wernicke's may rapidly resolve into conduction aphasia. • Transcortical Aphasias: ◦ Fluent (posterior): Posterior to Wernicke's area; common in posterior watershed zone infarctions or neoplasms. ◦ Nonfluent (anterior): Anterior to Broca's area; involves anterior watershed zone or supplementary motor cortex. • Global and Isolation Aphasias: ◦ Global: Combined dysfunction of Broca's and Wernicke's areas; results from strokes involving the entire MCA distribution in the left hemisphere. ◦ Isolation: Combination of two transcortical aphasias; associated with patchy lesions, anoxia, or complete watershed zone infarctions. • Anomic Aphasia: ◦ Location: Anywhere within the left hemisphere language network (e.g., middle and inferior temporal gyri). ◦ Prevalence: Most common language disturbance in head trauma, metabolic encephalopathy, and Alzheimer's disease. • Pure Word Deafness: ◦ Location: Bilateral or left-sided MCA strokes affecting the superior temporal gyrus. ◦ Mechanism: Interruption of flow from auditory association cortex to the language network. • Pure Alexia Without Agraphia: ◦ Location: Left occipital cortex and posterior sector of the corpus callosum (splenium). ◦ Mechanism: Interruption of visual input into the language network; often caused by PCA territory vascular lesions or infiltrating neoplasms.

Neurodegenerative Etiology¶

• Progressive Aphasia (PPA) Criteria: ◦ Diagnosis requires: Language disorder in relative isolation, primary concern for patient, and most salient deficit for 1–2 years. ◦ Pathologies: FTLD (tauopathy or TDP-43 proteinopathy) or Alzheimer's disease (AD). Rare cases of Creutzfeldt-Jacob disease (CJD). • Agrammatic PPA: ◦ Features: Low fluency, impaired grammar, intact word comprehension; resembles Broca's but lacks right hemiparesis and has more pronounced syntax issues. ◦ Pathology: FTLD (tauopathy) or atypical AD. • Semantic PPA: ◦ Features: Preserved fluency/syntax, poor single-word comprehension, profound two-way naming impairments; not seen in CVAs. ◦ Pathology: FTLD with abnormal precipitates of the 43-kDa transactive response DNA-binding protein TDP-43 of type C. • Logopenic PPA: ◦ Features: Preserved syntax/comprehension, severe word-finding pauses, anomia, circumlocutions; repetition impaired. ◦ Pathology: Most commonly associated with AD pathology.

ARIA and Anti-Aβ Therapy¶

• ARIA Definitions: ◦ ARIA-E: Amyloid-Related Imaging Abnormalities - Edema. ◦ ARIA-H: Amyloid-Related Imaging Abnormalities - Hemorrhage (microbleeds, superficial siderosis, or rarely macrohemorrhages). • Clinical Risks: ◦ Symptoms: Asymptomatic, mild (headache, dizziness, increased confusion), or severe (seizures, stroke-like episodes, death). ◦ Risk Factor: Higher in patients carrying one or two copies of APOε4. • Treatment Selection Criteria: 1. Early clinical stage of AD (MCI or mild dementia) based on daily function and cognitive testing. 2. Confirmation of amyloid pathology via PET or CSF biomarkers. 3. Absence of comorbidities or medications that may enhance risks.

CLINICAL FEATURES¶

• Assessment Components: ◦ Naming: Identify anomia (most common), semantic paraphasia (related word), or phonemic paraphasia (phonetically similar). ◦ Naming Deficits: ◦ One-way (retrieval-based): Patient cannot provide name but can point to object when name is provided. ◦ Two-way (comprehension-based/semantic): Patient cannot provide, define, or recognize the correct noun. ◦ Spontaneous Speech: ◦ Fluent: Maintains appropriate volume, phrase length, and melody. ◦ Nonfluent: Sparse and halting; average utterance < 4 words. ◦ Grammar: Assess syntax, tenses, suffixes, prefixes, plurals, and possessives. ◦ Comprehension: Follow conversation, answer yes-no questions, point to objects, decode passive voice, or define meanings. ◦ Repetition: Single words, short sentences, or strings (e.g., 'No if, ands, or buts'). ◦ Reading/Writing: Assess aloud reading and comprehension; agraphia = impaired spelling.

Aphasia Types & Characteristics¶

• Wernicke's Aphasia: ◦ Comprehension: Impaired. ◦ Fluency: Preserved or increased. ◦ Repetition/Naming: Impaired. • Broca's Aphasia: ◦ Comprehension: Preserved (except for complex syntax like passive voice). ◦ Fluency: Decreased (nonfluent, telegraphic). ◦ Repetition/Naming: Impaired. • Conduction Aphasia: ◦ Comprehension: Preserved. ◦ Fluency: Preserved (but with many phonemic paraphasias). ◦ Repetition: Severely impaired. • Transcortical Aphasias: ◦ Fluent (posterior): Similar to Wernicke's but repetition is intact. ◦ Nonfluent (anterior): Similar to Broca's but repetition is intact and agrammatism is less pronounced. • Global & Isolation: ◦ Global: Impaired comprehension, impaired repetition, impaired naming, decreased fluency. ◦ Isolation: Impaired comprehension, echolalia, impaired naming, no purposeful speech. • Anomic Aphasia: ◦ Comprehension/Repetition: Preserved. ◦ Fluency: Preserved (except for word-finding pauses). ◦ Naming: Impaired. • Pure Word Deafness: ◦ Comprehension: Impaired only for spoken language. ◦ Repetition: Impaired. ◦ Naming/Fluency: Preserved. • Pure Alexia: ◦ Comprehension: Impaired only for reading. ◦ Repetition/Naming/Fluency: Preserved.

DIFFERENTIAL DIAGNOSIS¶

• Stroke vs. Neurodegenerative: ◦ Stroke: Sudden onset, maximal deficit at start. ◦ Neurodegenerative: Gradual progression; specific patterns (e.g., PPA) identified by primary concern and duration (≥1 year). • PPA Subtypes: ◦ Agrammatic: Broca-like but with more severe syntax issues; less likely to have dysarthria. ◦ Semantic: Wernicke-like but with better repetition and worse naming/comprehension of nouns. ◦ Logopenic: Distinctive word-finding pauses; most common in AD.

DIAGNOSTIC APPROACH¶

Clinical Examination: • Assess naming (one-way vs. two-way), spontaneous speech (fluency/grammar), comprehension, repetition, reading, and writing. • Evaluate for specific syndromes: Gerstmann's (acalculia, dysgraphia, finger anomia, right-left confusion) and Bálint's (simultanagnosia, optic ataxia, oculomotor apraxia).
Imaging & Biomarkers: • MRI to identify stroke location or neurodegenerative patterns. • PET or CSF biomarkers to confirm amyloid pathology before initiating anti-Aβ therapy.

MANAGEMENT & TREATMENT¶

Anti-Aβ Mononuclear Antibody Therapy: • Candidate Selection: ◦ Early clinical stage of AD (MCI or mild dementia) based on function/cognition. ◦ Confirmation of amyloid pathology via PET or CSF biomarkers. ◦ Absence of high-risk comorbidities or medications. • Risk Management: ◦ Genotype for APOε4 to inform patients of higher ARIA risk. ◦ Contraindication: Thrombolytic agents are contraindicated in patients treated with anti-Aβ monoclonal antibodies.
Speech Therapy: ◦ More successful in Broca's aphasia than Wernicke's.
Caregiver Support: ◦ Provide support for patients with impaired communication.

SPECIAL CONSIDERATIONS¶

• Subcortical Aphasia: ◦ Result from lesions in white matter pathways. • Hemispatial Neglect: ◦ Cause: Right hemisphere lesion. ◦ Feature: Failure of attention to one side (usually left) of space; more severe/longer-lasting than left-sided deficits. • Bálint's Syndrome: ◦ Cause: Bilateral parietal lesions. ◦ Features: Simultanagnosia, optic ataxia, and oculomotor apraxia. • Posterior Cortical Atrophy (PCA): ◦ Definition: Atypical variant of Alzheimer's disease with parieto-occipital neurofibrillary degeneration. • Gerstmann's Syndrome: ◦ Cause: Inferior parietal lobule (angular gyrus) lesion. ◦ Features: Acalculia, dysgraphia, finger anomia, right-left confusion.

KEY PEARLS & CLINICAL TRAPS¶

• Aphasia vs. Dysarthria: Dysarthria, apraxia of speech, and mutism do not constitute aphasia. ◦ Distinction: Aphasia is a deficit in the formal aspects of language (word finding, repetition, word choice, comprehension, spelling, grammar). • Wernicke's Distinction: Ability to follow commands for axial muscles despite poor comprehension helps differentiate Wernicke's from deafness or psychiatric issues. ◦ Note: Wernicke's aphasia implies a cerebrovascular cause rather than neurodegenerative disease. • Broca's Insight: Patients with Broca's have preserved insight and are often frustrated; patients with Wernicke's may lack awareness of their deficits. • Pure Word Deafness/Alexia: These are disconnection syndromes, not primary sensory deficits. ◦ Pure word deafness: Interruption from auditory association cortex to the language network. ◦ Pure alexia: Interruption of visual input into the language network (splenium involvement). • PPA Diagnosis: Requires the language disorder to be the primary concern for at least 1–2 years.

Reference Tables¶

Harrison's 22e, p.201

	COMPREHENSION	REPETITION OF SPOKEN LANGUAGE	NAMING	FLUENCY
Wernicke’s	Impaired	Impaired	Impaired	Preserved or increased
	Preserved (except grammar)	Impaired	Impaired
Global	Impaired	Impaired	Impaired	Decreased
	Preserved	Impaired	Impaired
Nonfluent (anterior) transcortical	Preserved	Preserved	Impaired	Impaired
	Impaired	Preserved	Impaired
Isolation	Impaired	Echolalia	Impaired	No purposeful speech
	Preserved	Preserved	Impaired
Pure word deafness	Impaired only for spoken language	Impaired	Preserved	Preserved
	Impaired only for reading	Preserved	Preserved